STAGE II HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA AJCC V8
Clinical trials for STAGE II HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to ease agony of cancer treatment mouth sores
Symptom relief Recruiting nowThis study is testing whether adding an investigational drug called BMX-001 to standard symptom care can better prevent severe mouth sores in people receiving combined chemotherapy and radiation for head and neck cancer. About 98 participants will be randomly assigned to receive …
Matched conditions: STAGE II HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Apr 03, 2026 14:41 UTC
-
New hope to spare cancer patients from opioid addiction during treatment
Symptom relief Recruiting nowThis large, late-stage trial is testing if a high dose of the drug gabapentin, started early, can prevent the need for strong opioid painkillers in patients receiving chemotherapy and radiation for head and neck cancer. The goal is to manage the severe mouth sores and pain that a…
Matched conditions: STAGE II HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated Mar 06, 2026 15:38 UTC